Anebulo Pharmaceuticals Inc (ANEB)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ANEB market cap is 49.01M. The company's latest EPS is USD -0.4524 and P/E is -4.02.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.86M | -2.49M | -2.54M | -2.76M | -1.66M |
| Net Income | -2.8M | -2.5M | -2.48M | -2.72M | -1.65M |
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -174k | -3.61M | -6.83M | -11.78M |
| Net Income | -175k | -38.46M | -6.83M | -11.73M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 14.43M | 11.67M | 9.05M | 7.5M | 6M |
| Total Liabilities | 1.49M | 1.07M | 717k | 1.01M | 1.01M |
| Total Equity | 12.94M | 10.6M | 8.33M | 6.49M | 4.99M |
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.03M | 21.65M | 15.58M | 11.67M |
| Total Liabilities | 224k | 242k | 513k | 1.07M |
| Total Equity | -171k | 21.41M | 15.07M | 10.6M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -6.84M | -9.68M | -2.73M | -4.54M | -6.04M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6.45M | 6.38M | N/A | -62k | -62k |
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -151k | -4.87M | -5.44M | -9.68M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 3.18M | 21.83M | N/A | 6.38M |
| Market Cap | 49.01M |
| Price to Earnings Ratio | -4.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.2 |
| Price to Book Ratio | 4.45 |
| Dividend Yield | - |
| Shares Outstanding | 25.93M |
| Average Volume (1 week) | 43.84k |
| Average Volume (1 Month) | 15.08k |
| 52 Week Change | -42.55% |
| 52 Week High | 3.6099 |
| 52 Week Low | 1.62 |
| Spread (Intraday) | 0.27 (13.24%) |
| Company Name | Anebulo Pharmaceuticals Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.anebulo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
